2026. BLOOD-BASED BIOMARKERS FOR PREDICTING POST-STROKE PROGNOSIS: A SCOPING REVIEW OF PENTRAXIN-3, NEUROPENTRAXIN-1, AND NEUROPENTRAXIN-2. Magna Neurologica. 4, 2 (Jul. 2026), 175–186. DOI:https://doi.org/10.20961/magnaneurologica.v4i2.3308.